Sartorius AG (SRT3) Receives €78.40 Consensus Price Target from Brokerages

Sartorius AG (FRA:SRT3) has received a consensus rating of “Hold” from the ten brokerages that are currently covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and two have issued a buy recommendation on the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is €78.40 ($93.33).

A number of analysts recently weighed in on SRT3 shares. Berenberg Bank set a €85.00 ($101.19) price objective on shares of Sartorius and gave the stock a “buy” rating in a research report on Wednesday, October 25th. Warburg Research set a €100.00 ($119.05) price objective on shares of Sartorius and gave the stock a “buy” rating in a research report on Wednesday, October 25th. Deutsche Bank set a €88.00 ($104.76) price objective on shares of Sartorius and gave the stock a “neutral” rating in a research report on Tuesday, October 17th. Commerzbank set a €87.00 ($103.57) price objective on shares of Sartorius and gave the stock a “neutral” rating in a research report on Tuesday, October 17th. Finally, UBS Group set a €85.00 ($101.19) price objective on shares of Sartorius and gave the stock a “neutral” rating in a research report on Tuesday, October 17th.

Shares of Sartorius (FRA SRT3) traded down €0.75 ($0.89) during midday trading on Monday, hitting €87.25 ($103.87). 52,634 shares of the stock traded hands. The stock has a market cap of $6,360.00 and a PE ratio of 70.93. Sartorius has a 52-week low of €63.72 ($75.86) and a 52-week high of €94.00 ($111.90).

ILLEGAL ACTIVITY NOTICE: “Sartorius AG (SRT3) Receives €78.40 Consensus Price Target from Brokerages” was published by Community Financial News and is owned by of Community Financial News. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark law. The correct version of this news story can be viewed at https://www.com-unik.info/2018/01/18/sartorius-ag-srt3-receives-78-40-consensus-price-target-from-brokerages.html.

Sartorius Company Profile

Sartorius Aktiengesellschaft provides laboratory and process technologies and equipment worldwide. The company operates through two divisions, Bioprocess Solutions, and Lab Products & Services. The Bioprocess Solutions division offers products, technologies, and services ranging from fermentation, cell cultivation, filtration, and purification to media storage and transportation for the biopharmaceutical industry.

Analyst Recommendations for Sartorius (FRA:SRT3)

Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit